Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death

Ming Shao(Chinese Academy of Sciences), Chaoyang Li(Chinese Academy of Sciences)
Frontiers in Oncology
May 18, 2021
Cited by 13


Related Papers